Table III.
Parameters | Discrepant diagnoses (n=50) | Accordant diagnoses (n=27) | χ2 | P-value |
---|---|---|---|---|
Female | 44 | 23 | 0.123 | 0.734 |
Concurrent autoimmune diseases | 31 | 13 | 1.374 | 0.335 |
ALP:AST ratio | 0.932 | 0.628 | ||
1.5–3 | 7 | 3 | ||
<1.5 | 39 | 20 | ||
IgG | 4.013 | 0.134 | ||
Normal | 10 | 1 | ||
Abnormal | 40 | 26 | ||
ANA or SMA | 15.000 | 0.001 | ||
1:80>x≥1:40 | 15 | 4 | ||
≥1:80 | 11 | 18 | ||
Anti-SLA/LP or pANCA | 8 | 6 | 0.456 | 0.499 |
Liver histology | 6.517 | 0.038 | ||
Not tested | 28 | 16 | ||
Compatible | 22 | 8 | ||
Typical | 0 | 3 |
ALP, alkaline phosphatase; AST, aspartate aminotransferase; IgG, immunoglobulin G; ANA, antinuclear antibody; SLA/LP, soluble liver antigen/liver-pancreas antigen; pANCA, perinuclear antineutrophil cytoplasmic antibody.